Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177Paul D. Brown, Jan C. Buckner, William H. Yong et al.|Journal of Clinical Oncology|2008Cited by 275